NCT03639428View on ClinicalTrials.gov

Pharmacokinetic Evaluation of MDZ028

CompletedOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

June 23, 2011

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Midazolam
Interventions
DRUG

Midazolam

All subjects received a sigle 0.3mg/kg midazolam dose os ADV6209

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT03639428 - Pharmacokinetic Evaluation of MDZ028 | Biotech Hunter | Biotech Hunter